Euthymics Bioscience, Inc. announced it raised $300,000 in an initial filing from an offering of $500,000

Jun 01, 2017•about 8 years ago

Amount Raised

$300,000

Round Type

seed

CambridgeBiotechnology

Company Information

Company

Euthymics Bioscience, Inc.

Location

43 THORNDIKE STREET, SUITE S1-3

Cambridge, Maryland, United States

About

Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech